Veerasikku Gopal Deepagan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Veerasikku Gopal Deepagan has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Jae Hyung Park
Department of Intelligent Electronics and Computer Engineering, Chonnam National University, Gwangju 61186, Republic of Korea
14 shared publications Hyewon Ko
Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Suwon 16419, Republic of Korea
9 shared publications- Thavasyappan Thambi
Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin si, Republic of Korea
9 shared publications Doo Sung Lee
School of Chemical Engineering, College of Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea
7 shared publicationsDong Gil You
School of Chemical Engineering, College of Engineering, Sungkyunkwan University , Suwon 16419, Republic of Korea
6 shared publicationsSeunglee Kwon
School of Chemical Engineering, College of Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea
6 shared publications
Latest Publications
- 12 October 2021
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 13 (42) , 49581-49588
Bright Future of Gold Nanoclusters in Theranostics
Quantum-sized gold nanoclusters (AuNCs) are emerging as theranostic agents–those that combine diagnostics and therapeutic properties–given their ultrasmall size <3 nm, which makes them behave more like a molecule rather than a nanoparticle. This molecule-like behavior endows AuNCs with interesting properties including photoluminescence, catalytic activity, and paramagnetism–all without the presence of any toxic heavy metal. But despite these fundamental advances, scalable synthetic approaches to produce high-quality AuNCs with well-controlled and programmable properties for biological applications as well as methods to determine their structure–property relationships are not widely available. In this Perspective, we will discuss what is known so far about AuNCs as well as how to move forward to propel AuNCs as a theranostic agent of choice for many biomedical applications.
- 12 October 2021
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 13 (42) , 49581-49588
Bright Future of Gold Nanoclusters in Theranostics
Quantum-sized gold nanoclusters (AuNCs) are emerging as theranostic agents–those that combine diagnostics and therapeutic properties–given their ultrasmall size <3 nm, which makes them behave more like a molecule rather than a nanoparticle. This molecule-like behavior endows AuNCs with interesting properties including photoluminescence, catalytic activity, and paramagnetism–all without the presence of any toxic heavy metal. But despite these fundamental advances, scalable synthetic approaches to produce high-quality AuNCs with well-controlled and programmable properties for biological applications as well as methods to determine their structure–property relationships are not widely available. In this Perspective, we will discuss what is known so far about AuNCs as well as how to move forward to propel AuNCs as a theranostic agent of choice for many biomedical applications.
- 22 December 2020
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 21 (1) , 476-484
Engineering Fluorescent Gold Nanoclusters Using Xanthate-Functionalized Hydrophilic Polymers: Toward Enhanced Monodispersity and Stability
We introduce xanthate-functionalized poly(cyclic imino ethers)s (PCIEs), specifically poly(2-ethyl-2-oxazoline) and poly(2-ethyl-2-oxazine) given their stealth characteristics, as an attractive alternative to conventional thiol-based ligands for the synthesis of highly monodisperse and fluorescent gold nanoclusters (AuNCs). The xanthate in the PCIEs interacts with Au ions, acting as a well-controlled template for the direct formation of PCIE-AuNCs. This method yields red-emitting AuNCs with a narrow emission peak (λem = 645 nm), good quantum yield (4.3–4.8%), long fluorescence decay time (∼722–844 ns), and unprecedented product yield (>98%). The PCIE-AuNCs exhibit long-term colloidal stability, biocompatibility, and antifouling properties, enabling a prolonged blood circulation, lower nonspecific accumulation in major organs, and better renal clearance when compared with AuNCs without polymer coating. The advances made here in the synthesis of metal nanoclusters using xanthate-functionalized PCIEs could propel the production of highly monodisperse, biocompatible, and renally clearable nanoprobes in large-scale for different theranostic applications.
- 22 December 2020
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 21 (1) , 476-484
Engineering Fluorescent Gold Nanoclusters Using Xanthate-Functionalized Hydrophilic Polymers: Toward Enhanced Monodispersity and Stability
We introduce xanthate-functionalized poly(cyclic imino ethers)s (PCIEs), specifically poly(2-ethyl-2-oxazoline) and poly(2-ethyl-2-oxazine) given their stealth characteristics, as an attractive alternative to conventional thiol-based ligands for the synthesis of highly monodisperse and fluorescent gold nanoclusters (AuNCs). The xanthate in the PCIEs interacts with Au ions, acting as a well-controlled template for the direct formation of PCIE-AuNCs. This method yields red-emitting AuNCs with a narrow emission peak (λem = 645 nm), good quantum yield (4.3–4.8%), long fluorescence decay time (∼722–844 ns), and unprecedented product yield (>98%). The PCIE-AuNCs exhibit long-term colloidal stability, biocompatibility, and antifouling properties, enabling a prolonged blood circulation, lower nonspecific accumulation in major organs, and better renal clearance when compared with AuNCs without polymer coating. The advances made here in the synthesis of metal nanoclusters using xanthate-functionalized PCIEs could propel the production of highly monodisperse, biocompatible, and renally clearable nanoprobes in large-scale for different theranostic applications.
- 1 October 2018
- Published by Elsevier in Acta Biomaterialia
- Vol. 79, 294-305
Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration
- 1 October 2018
- Published by Elsevier in Acta Biomaterialia
- Vol. 79, 294-305
Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration
- 1 July 2018
- Published by Springer Nature in Macromolecular Research
- Vol. 26 (7) , 577-580
PEGylated Gold Nanoprobe Bearing the Diselenide Bond for ROS-Responsive Fluorescence Imaging
- 1 July 2018
- Published by Springer Nature in Macromolecular Research
- Vol. 26 (7) , 577-580
PEGylated Gold Nanoprobe Bearing the Diselenide Bond for ROS-Responsive Fluorescence Imaging
- 1 April 2018
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 110, 406-415
Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy
- 1 April 2018
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 110, 406-415
Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy
- 9 March 2018
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 18 (4) , 2637-2644
Intracellularly Activatable Nanovasodilators To Enhance Passive Cancer Targeting Regime
Conventional cancer targeting with nanoparticles has been based on the assumed enhanced permeability and retention (EPR) effect. The data obtained in clinical trials to date, however, have rarely supported the presence of such an effect. To address this challenge, we formulated intracellular nitric oxide-generating nanoparticles (NO-NPs) for the tumor site-specific delivery of NO, a well-known vasodilator, with the intention of boosting EPR. These nanoparticles are self-assembled under aqueous conditions from amphiphilic copolymers of poly(ethylene glycol) and nitrated dextran, which possesses inherent NO release properties in the reductive environment of cancer cells. After systemic administration of the NO-NPs, we quantitatively assessed and visualized increased tumor blood flow as well as enhanced vascular permeability than could be achieved without NO. Additionally, we prepared doxorubicin (DOX)-encapsulated NO-NPs and demonstrated consequential improvement in therapeutic efficacy over the control groups with considerably improved DOX intratumoral accumulation. Overall, this proof of concept study implies a high potency of the NO-NPs as an EPR enhancer to achieve better clinical outcomes.
- 9 March 2018
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 18 (4) , 2637-2644
Intracellularly Activatable Nanovasodilators To Enhance Passive Cancer Targeting Regime
Conventional cancer targeting with nanoparticles has been based on the assumed enhanced permeability and retention (EPR) effect. The data obtained in clinical trials to date, however, have rarely supported the presence of such an effect. To address this challenge, we formulated intracellular nitric oxide-generating nanoparticles (NO-NPs) for the tumor site-specific delivery of NO, a well-known vasodilator, with the intention of boosting EPR. These nanoparticles are self-assembled under aqueous conditions from amphiphilic copolymers of poly(ethylene glycol) and nitrated dextran, which possesses inherent NO release properties in the reductive environment of cancer cells. After systemic administration of the NO-NPs, we quantitatively assessed and visualized increased tumor blood flow as well as enhanced vascular permeability than could be achieved without NO. Additionally, we prepared doxorubicin (DOX)-encapsulated NO-NPs and demonstrated consequential improvement in therapeutic efficacy over the control groups with considerably improved DOX intratumoral accumulation. Overall, this proof of concept study implies a high potency of the NO-NPs as an EPR enhancer to achieve better clinical outcomes.
- 1 December 2017
- Published by Elsevier in Journal of Controlled Release
- Vol. 267, 181-190
A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy
- 1 December 2017
- Published by Elsevier in Journal of Controlled Release
- Vol. 267, 181-190
A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy
- Top Cited Papers
- 3 October 2016
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 16 (10) , 6257-6264
Long-Circulating Au-TiO2Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Cancer
Although sonodynamic therapy (SDT) has emerged as a potential alternative to conventional photodynamic therapy, the low quantum yield of the sonosensitizer such as TiO2 nanoparticles (NPs) is still a major concern. Here, we have developed hydrophilized Au-TiO2 nanocomposites (HAu-TiO2 NCs) as sonosensitizers for improved SDT. The physicochemical properties of HAu-TiO2 NCs were thoroughly studied and compared with their counterparts without gold deposition. Upon exposure of HAu-TiO2 NCs to ultrasound, a large quantity of reactive oxygen species (ROS) were generated, leading to complete suppression of tumor growth after their systemic administration in vivo. Overall, it was evident that the composites of gold with TiO2 NPs significantly augmented the levels of ROS generation, implying their potential as SDT agents for cancer therapy.
- 3 October 2016
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 16 (10) , 6257-6264
Top Cited PapersLong-Circulating Au-TiO2Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Cancer
Although sonodynamic therapy (SDT) has emerged as a potential alternative to conventional photodynamic therapy, the low quantum yield of the sonosensitizer such as TiO2 nanoparticles (NPs) is still a major concern. Here, we have developed hydrophilized Au-TiO2 nanocomposites (HAu-TiO2 NCs) as sonosensitizers for improved SDT. The physicochemical properties of HAu-TiO2 NCs were thoroughly studied and compared with their counterparts without gold deposition. Upon exposure of HAu-TiO2 NCs to ultrasound, a large quantity of reactive oxygen species (ROS) were generated, leading to complete suppression of tumor growth after their systemic administration in vivo. Overall, it was evident that the composites of gold with TiO2 NPs significantly augmented the levels of ROS generation, implying their potential as SDT agents for cancer therapy.
- 1 October 2016
- Published by Elsevier in Biomaterials
- Vol. 103, 56-66
In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery
- 1 October 2016
- Published by Elsevier in Biomaterials
- Vol. 103, 56-66
In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery
- Top Cited PapersOpen Access
- 21 March 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 23200
ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer
The non-invasive photodynamic therapy has been limited to treat superficial tumours, primarily ascribed to poor tissue penetration of light as the energy source. Herein, we designed a long-circulating hydrophilized titanium dioxide nanoparticle (HTiO2 NP) that can be activated by ultrasound to generate reactive oxygen species (ROS). When administered systemically to mice, HTiO2 NPs effectively suppressed the growth of superficial tumours after ultrasound treatments. In tumour tissue, the levels of proinflammatory cytokines were elevated several fold and intense vascular damage was observed. Notably, ultrasound treatments with HTiO2 NPs also suppressed the growth of deeply located liver tumours at least 15-fold, compared to animals without ultrasound treatments. This study provides the first demonstration of the feasibility of using HTiO2 NPs as sensitizers for sonodynamic therapy in vivo.
- 21 March 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 23200
Top Cited PapersOpen AccessROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer
The non-invasive photodynamic therapy has been limited to treat superficial tumours, primarily ascribed to poor tissue penetration of light as the energy source. Herein, we designed a long-circulating hydrophilized titanium dioxide nanoparticle (HTiO2 NP) that can be activated by ultrasound to generate reactive oxygen species (ROS). When administered systemically to mice, HTiO2 NPs effectively suppressed the growth of superficial tumours after ultrasound treatments. In tumour tissue, the levels of proinflammatory cytokines were elevated several fold and intense vascular damage was observed. Notably, ultrasound treatments with HTiO2 NPs also suppressed the growth of deeply located liver tumours at least 15-fold, compared to animals without ultrasound treatments. This study provides the first demonstration of the feasibility of using HTiO2 NPs as sensitizers for sonodynamic therapy in vivo.